A Phase 2 AMPLIFY trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Latest Information Update: 01 Dec 2025
At a glance
- Drugs HU 6 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Acronyms AMPLIFY
Most Recent Events
- 01 Dec 2025 New trial record